Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1987 1
1990 1
1995 1
1999 1
2000 1
2001 1
2005 2
2006 1
2008 4
2009 2
2010 2
2013 2
2014 5
2015 5
2016 3
2017 5
2018 6
2019 1
2020 4
2021 10
2022 12
2023 4
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Encuestas de satisfacción al personal facultativo y de enfermería como método de mejora de la calidad de los procesos del servicio de farmacia.
Giménez Manzorro A, Vigil D, Durán García ME, Fernández-Llamazares CM, Lobato Matilla E, Caro González L, Sanjurjo M. Giménez Manzorro A, et al. Among authors: sanjurjo m. Rev Calid Asist. 2008 Jan;23(1):3-6. doi: 10.1016/S1134-282X(08)70459-7. Epub 2008 Oct 11. Rev Calid Asist. 2008. PMID: 23040037 Spanish.
Medication guide for the perioperative management of oral antineoplastic agents in cancer patients.
Villanueva-Bueno C, Escudero-Vilaplana V, Collado-Borrell R, Giménez-Manzorro Á, Ribed A, Marzal-Alfaro B, Revuelta-Herrero JL, Gonzalez-Haba E, Herranz A, Sanjurjo M. Villanueva-Bueno C, et al. Among authors: sanjurjo m. Expert Opin Drug Saf. 2022 Jan;21(1):107-119. doi: 10.1080/14740338.2021.1965990. Epub 2021 Aug 12. Expert Opin Drug Saf. 2022. PMID: 34357828 Review.
Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction.
González MM, Sanz-Pastor AG, Gómez RÁ, Torrecilla NB, Moreno DM, Fernández LG, Rivas AM, Guerra AL, Álvarez R, Arranz JÁ, Rodas IM, Escudero V, Sanjurjo M, Vallejo JM, Martín M, Albarrán OG. González MM, et al. Among authors: sanjurjo m. Endocr Metab Immune Disord Drug Targets. 2024;24(14):1628-1639. doi: 10.2174/0118715303280679240206100137. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38362680
Direct costs of a home parenteral nutrition programme.
Arhip L, García-Peris P, Romero RM, Frías L, Bretón I, Camblor M, Motilla M, Velasco C, Morales A, Carrascal ML, Herranz A, Sanjurjo M, Cuerda C. Arhip L, et al. Among authors: sanjurjo m. Clin Nutr. 2019 Aug;38(4):1945-1951. doi: 10.1016/j.clnu.2018.06.972. Epub 2018 Jun 28. Clin Nutr. 2019. PMID: 30005903
Possible heart failure caused by osimertinib in a lung cancer patient.
Ruiz-Briones P, Escudero-Vilaplana V, Collado-Borrell R, Vicente-Valor J, Alvarez R, Villanueva-Bueno C, Narrillos-Moraza Á, Herranz A, Sanjurjo M. Ruiz-Briones P, et al. Among authors: sanjurjo m. J Oncol Pharm Pract. 2023 Jun;29(4):1015-1020. doi: 10.1177/10781552221143787. Epub 2022 Dec 8. J Oncol Pharm Pract. 2023. PMID: 36480925
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.
Escudero-Vilaplana V, Collado-Borrell R, Gómez Martínez-Sagrera P, Villanueva-Bueno C, Revuelta-Herrero JL, Gonzalez-Haba E, Hoyo-Muñoz Á, Jerez Gilarranz Y, Marzal-Alfaro B, Herranz A, Martin M, Sanjurjo M. Escudero-Vilaplana V, et al. Among authors: sanjurjo m. J Cancer Res Clin Oncol. 2023 Jul;149(7):2855-2882. doi: 10.1007/s00432-022-04172-1. Epub 2022 Jul 6. J Cancer Res Clin Oncol. 2023. PMID: 35790560
65 results